About Ajay Raju
Form D filings for Avstera Therapeutics from 2022 to 2023 list Ajay Raju as co-founder and director.
Ajay Raju first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Ajay Raju in the role, so the role may have started earlier or lasted longer.